open access

Vol 86, No 2 (2015)
ARTICLES
Get Citation

The role of chemokine and non-chemokine factors in pain-related complaints in patients with endometrial cysts

Karolina Chmaj-Wierzchowska, Małgorzata Kampioni, Maciej Wilczak, Stefan Sajdak, Tomasz Opala
DOI: 10.17772/gp/1994
·
Ginekol Pol 2015;86(2).

open access

Vol 86, No 2 (2015)
ARTICLES

Abstract

Objectives: Endometriosis is a chronic disease manifested as peritoneal endometrial implants and adhesions, as well as endometrial cysts, with pain as the dominant component. The aim: The aim of the study was to evaluate the role of chemokine (MCP-1, MCP-2, MIP-1α, MIP-1β and RANTES) and non-chemokine (urocortin, ghrelin, and leptin) factors in the intensity of pelvic pain in women with endometrial cysts. Material and methods: A total of 86 women, aged 18-38, treated laparoscopically between September 2009 and November 2012, due to adnexal changes, i.e. endometrial cysts and mature teratomas, were recruited for the study. On a numeric rating scale, i.e. PSS (Pain Sensation Scale – according to Johnson), the patients rated pain intensity. The level of pain-related stress was investigated with the Pain Distress Scale (PDS, according to Johnson). Results: Medians for MCP-1, MCP-2, MIP-1α, MIP-1β and RANTES concentrations were not statistically significantly different. The respondents rated pain intensity during menses as 6 and 3 points in the E and T groups, respectively (6 vs. 3 points; p=0.001). Statistically significant differences were also observed for pain intensity during work (apart from menses), (2 vs. 2 points, p=0,014) and during sexual intercourse (apart from menses) (3 vs. 1 points, p=0.006). Pain-related stress levels were higher in the T group as compared to the E group (3 vs. 5 points; p=0.007). Conclusions: It seems safe to conclude that chemokines and leptin may play a significant role in the occurrence of pain complaints among women with endometrial cysts. Further research might result in implementation of new treatment methods for pain management, especially in terms of pharmacotherapy.

Abstract

Objectives: Endometriosis is a chronic disease manifested as peritoneal endometrial implants and adhesions, as well as endometrial cysts, with pain as the dominant component. The aim: The aim of the study was to evaluate the role of chemokine (MCP-1, MCP-2, MIP-1α, MIP-1β and RANTES) and non-chemokine (urocortin, ghrelin, and leptin) factors in the intensity of pelvic pain in women with endometrial cysts. Material and methods: A total of 86 women, aged 18-38, treated laparoscopically between September 2009 and November 2012, due to adnexal changes, i.e. endometrial cysts and mature teratomas, were recruited for the study. On a numeric rating scale, i.e. PSS (Pain Sensation Scale – according to Johnson), the patients rated pain intensity. The level of pain-related stress was investigated with the Pain Distress Scale (PDS, according to Johnson). Results: Medians for MCP-1, MCP-2, MIP-1α, MIP-1β and RANTES concentrations were not statistically significantly different. The respondents rated pain intensity during menses as 6 and 3 points in the E and T groups, respectively (6 vs. 3 points; p=0.001). Statistically significant differences were also observed for pain intensity during work (apart from menses), (2 vs. 2 points, p=0,014) and during sexual intercourse (apart from menses) (3 vs. 1 points, p=0.006). Pain-related stress levels were higher in the T group as compared to the E group (3 vs. 5 points; p=0.007). Conclusions: It seems safe to conclude that chemokines and leptin may play a significant role in the occurrence of pain complaints among women with endometrial cysts. Further research might result in implementation of new treatment methods for pain management, especially in terms of pharmacotherapy.
Get Citation

Keywords

MCP-1 / MCP-2 / MIP-1α / MIP-1β i RANTES / pain / endometriomas /

About this article
Title

The role of chemokine and non-chemokine factors in pain-related complaints in patients with endometrial cysts

Journal

Ginekologia Polska

Issue

Vol 86, No 2 (2015)

DOI

10.17772/gp/1994

Bibliographic record

Ginekol Pol 2015;86(2).

Keywords

MCP-1 / MCP-2 / MIP-1α / MIP-1β i RANTES / pain / endometriomas /

Authors

Karolina Chmaj-Wierzchowska
Małgorzata Kampioni
Maciej Wilczak
Stefan Sajdak
Tomasz Opala

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl